Logotype for 10X Genomics Inc

10X Genomics (TXG) investor relations material

10X Genomics Morgan Stanley 23rd Annual Global Healthcare Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for 10X Genomics Inc
Morgan Stanley 23rd Annual Global Healthcare Conference summary10 Sep, 2025

Key achievements and operational highlights

  • Completed commercial restructuring and made significant progress in product development, including the upcoming launch of Chromium Single Cell Gene Expression Flex V2.

  • Maintained strong cost management and further strengthened the balance sheet, positioning well for future growth.

  • Biopharma segment reorganized for better focus and visibility, with continued challenges in biotech funding but stable momentum in large pharma.

  • Majority of customers have transitioned to GenX consumables, with NextGen being phased out to accelerate final conversions.

  • Strategic acquisition of Scale Biosciences to enhance barcoding and scaling capabilities in single cell analysis.

Market environment and customer sentiment

  • Academic end markets remain cautious due to ongoing funding uncertainties, especially in the U.S., with no significant change in sentiment recently.

  • Global environment for capital equipment purchases is subdued, with increased scrutiny and pressure on instrument investments.

  • Biopharma customers, especially biotech, continue to face funding challenges, while large pharma remains cautious amid policy uncertainties.

  • Preference for consumables over capital equipment persists, with strong interest in both single cell and spatial applications.

Product innovation and competitive positioning

  • Chromium Flex V2 is set to launch later this year, offering enhanced sensitivity, robustness, and flexibility for large-scale and translational applications.

  • Flex V2 expected to enable new workflows and support the development of large-scale AI models in biology.

  • Single cell market shows strong elasticity, with lower price points driving increased reaction volumes and new applications.

  • Competitive landscape remains favorable, with superior data quality, sensitivity, and customer support cited as key differentiators.

  • Recent product introductions and the Scale acquisition address cost and scalability, further strengthening market position.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next 10X Genomics earnings date

Logotype for 10X Genomics Inc
Q3 20256 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next 10X Genomics earnings date

Logotype for 10X Genomics Inc
Q3 20256 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

10x Genomics, Inc. is a life science technology company that develops and sells instruments, consumables, and software for analyzing biological systems. The Company's proprietary sequencing technology establishes the framework for interrogating vast amounts of genetic information from thousands of samples at a cost and speed that rivals other sequencing methodology. Its products can obtain billions of sequence reads within a few days to weeks in order to support complex experiments and provide high-quality results that accurately reflect genetic variation across the human genome.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage